Cotinga Pharmaceuticals
London
About Cotinga Pharmaceuticals
Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner. Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2017)
- Ticker: cve:COT
- Website: criticaloutcome.com
- Phone: 1-800-798-8680
Industries & Categories
Biotechnology, Developer Platform, Ediscovery, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cotinga-pharmaceuticals-2204343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.